Single high-dose recombinant human granulocyte-macrophage colony stimulating factor: results of a phase I tolerability study

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Leukemia·2017

Alloreactivity: the Janus-face of hematopoietic stem cell transplantation.

Leukemia·2017

Latin America: the next region for haematopoietic transplant progress.

Bone marrow transplantation·2017

The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis.

Bone marrow transplantation·2016

Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia: 17 Cases. Report of the EBMT.

Leukemia & lymphoma·2016

Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey.

Bone marrow transplantation·2016

Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Correction: Induced pluripotent stem cells as natural biofactories for exosomes carrying miR-199b-5p in the treatment of spinal cord injury.

Frontiers in pharmacology·2026

Repetitive transcranial magnetic stimulation: advances for psychiatric disorders.

Frontiers in psychiatry·2026

Advances in the clinical application of stellate ganglion block for non-pain indications.

Frontiers in medicine·2026

Correction: In-network multidisciplinary digital care improves outcomes in medicare advantage members with musculoskeletal diagnoses.

Frontiers in digital health·2026

Adaptation of the Yield-Scaling Factor to Reduce Target Yield Deviation and Donation Time in Pathogen-Reduced Apheresis Platelet Collections Using the Sysmex XN1000 Blood Bank Mode.

Annals of laboratory medicine·2026

The Trodden and Untrodden Path: Mentorship, Innovation, and Leadership in Dermatology.

Dermatologic clinics·2026

Related Experiment Videos

Single high-dose recombinant human granulocyte-macrophage colony stimulating factor: results of a phase I

Related Concept Videos

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Alloreactivity: the Janus-face of hematopoietic stem cell transplantation.

Latin America: the next region for haematopoietic transplant progress.

The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis.

Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia: 17 Cases. Report of the EBMT.

Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey.

Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.

Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.

Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.

Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.

Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.

Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).

Correction: Induced pluripotent stem cells as natural biofactories for exosomes carrying miR-199b-5p in the treatment of spinal cord injury.

Repetitive transcranial magnetic stimulation: advances for psychiatric disorders.

Advances in the clinical application of stellate ganglion block for non-pain indications.

Correction: In-network multidisciplinary digital care improves outcomes in medicare advantage members with musculoskeletal diagnoses.

Adaptation of the Yield-Scaling Factor to Reduce Target Yield Deviation and Donation Time in Pathogen-Reduced Apheresis Platelet Collections Using the Sysmex XN1000 Blood Bank Mode.

The Trodden and Untrodden Path: Mentorship, Innovation, and Leadership in Dermatology.

Related Experiment Videos

Single high-dose recombinant human granulocyte-macrophage colony stimulating factor: results of a phase I...

Related Concept Videos

Related Articles

Single high-dose recombinant human granulocyte-macrophage colony stimulating factor: results of a phase I